125 related articles for article (PubMed ID: 11317281)
1. Leukemia inhibitory factor enhances regeneration in skeletal muscles after myoblast transplantation.
White JD; Bower JJ; Kurek JB; Austin L
Muscle Nerve; 2001 May; 24(5):695-7. PubMed ID: 11317281
[TBL] [Abstract][Full Text] [Related]
2. Leukaemia inhibitory factor increases myoblast replication and survival and affects extracellular matrix production: combined in vivo and in vitro studies in post-natal skeletal muscle.
White JD; Davies M; Grounds MD
Cell Tissue Res; 2001 Oct; 306(1):129-41. PubMed ID: 11683174
[TBL] [Abstract][Full Text] [Related]
3. Leukemia inhibitory factor (LIF) infusion stimulates skeletal muscle regeneration after injury: injured muscle expresses lif mRNA.
Barnard W; Bower J; Brown MA; Murphy M; Austin L
J Neurol Sci; 1994 May; 123(1-2):108-13. PubMed ID: 8064301
[TBL] [Abstract][Full Text] [Related]
4. The role of leukemia inhibitory factor in skeletal muscle regeneration.
Kurek JB; Bower JJ; Romanella M; Koentgen F; Murphy M; Austin L
Muscle Nerve; 1997 Jul; 20(7):815-22. PubMed ID: 9179153
[TBL] [Abstract][Full Text] [Related]
5. Leukemia inhibitory factor ameliorates muscle fiber degeneration in the mdx mouse.
Austin L; Bower JJ; Bennett TM; Lynch GS; Kapsa R; White JD; Barnard W; Gregorevic P; Byrne E
Muscle Nerve; 2000 Nov; 23(11):1700-5. PubMed ID: 11054748
[TBL] [Abstract][Full Text] [Related]
6. Leukaemia inhibitory factor treatment stimulates muscle regeneration in the mdx mouse.
Kurek J; Bower J; Romanella M; Austin L
Neurosci Lett; 1996 Jul; 212(3):167-70. PubMed ID: 8843099
[TBL] [Abstract][Full Text] [Related]
7. Functional properties of regenerating skeletal muscle following LIF administration.
Gregorevic P; Hayes A; Lynch GS; Williams DA
Muscle Nerve; 2000 Oct; 23(10):1586-8. PubMed ID: 11003796
[TBL] [Abstract][Full Text] [Related]
8. Losartan enhances the success of myoblast transplantation.
Fakhfakh R; Lamarre Y; Skuk D; Tremblay JP
Cell Transplant; 2012; 21(1):139-52. PubMed ID: 21535912
[TBL] [Abstract][Full Text] [Related]
9. Leukemia inhibitory factor enhances the regeneration of transected rat sciatic nerve and the function of reinnervated muscle.
Tham S; Dowsing B; Finkelstein D; Donato R; Cheema SS; Bartlett PF; Morrison WA
J Neurosci Res; 1997 Jan; 47(2):208-15. PubMed ID: 9008151
[TBL] [Abstract][Full Text] [Related]
10. Induction of CCAAT/Enhancer-Binding Protein β Expression With the Phosphodiesterase Inhibitor Isobutylmethylxanthine Improves Myoblast Engraftment Into Dystrophic Muscle.
Lala-Tabbert N; Fu D; Wiper-Bergeron N
Stem Cells Transl Med; 2016 Apr; 5(4):500-10. PubMed ID: 26941360
[TBL] [Abstract][Full Text] [Related]
11. Postnatal profiles of myogenic regulatory factors and the receptors of TGF-beta 2, LIF and IGF-I in the gastrocnemius and rectus femoris muscles of dy mouse.
Sakuma K; Watanabe K; Sano M; Uramoto I; Totsuka T
Acta Neuropathol; 2000 Feb; 99(2):169-76. PubMed ID: 10672324
[TBL] [Abstract][Full Text] [Related]
12. An evaluation of leukaemia inhibitory factor as a potential therapeutic agent in the treatment of muscle disease.
White JD; Davies M; McGeachie J; Grounds MD
Neuromuscul Disord; 2002 Dec; 12(10):909-16. PubMed ID: 12467745
[TBL] [Abstract][Full Text] [Related]
13. Controlled release of leukaemia inhibitory factor (LIF) to tissues.
Austin L; Bower JJ; Kurek JB; Muldoon CM
Growth Factors; 1997; 15(1):61-8. PubMed ID: 9401818
[TBL] [Abstract][Full Text] [Related]
14. In vitro myoblast to myotube transformations in the presence of leukemia inhibitory factor.
Vakakis N; Bower J; Austin L
Neurochem Int; 1995; 27(4-5):329-35. PubMed ID: 8845733
[TBL] [Abstract][Full Text] [Related]
15. Effects of omega-3 on matrix metalloproteinase-9, myoblast transplantation and satellite cell activation in dystrophin-deficient muscle fibers.
de Carvalho SC; Hindi SM; Kumar A; Marques MJ
Cell Tissue Res; 2017 Sep; 369(3):591-602. PubMed ID: 28623422
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of increasing dystrophin-positive myofibers by myoblast transplantation: study using mdx/beta-galactosidase transgenic mice.
Kinoshita I; Vilquin JT; Tremblay JP
Acta Neuropathol; 1996; 91(5):489-93. PubMed ID: 8740229
[TBL] [Abstract][Full Text] [Related]
17. AM424: history of a novel drug candidate.
Kurek J
Clin Exp Pharmacol Physiol; 2000 Jul; 27(7):553-7. PubMed ID: 10874517
[TBL] [Abstract][Full Text] [Related]
18. Myoblast transfer in the treatment of Duchenne's muscular dystrophy.
Mendell JR; Kissel JT; Amato AA; King W; Signore L; Prior TW; Sahenk Z; Benson S; McAndrew PE; Rice R
N Engl J Med; 1995 Sep; 333(13):832-8. PubMed ID: 7651473
[TBL] [Abstract][Full Text] [Related]
19. Effects of leukemia inhibitory factor on rat skeletal muscles are modulated by clenbuterol.
Gregorevic P; Williams DA; Lynch GS
Muscle Nerve; 2002 Feb; 25(2):194-201. PubMed ID: 11870686
[TBL] [Abstract][Full Text] [Related]
20. Complement and myoblast transfer therapy: donor myoblast survival is enhanced following depletion of host complement C3 using cobra venom factor, but not in the absence of C5.
Hodgetts SI; Grounds MD
Immunol Cell Biol; 2001 Jun; 79(3):231-9. PubMed ID: 11380675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
